Fas-mediated apoptosis in adriamycin-induced cardiomyopathy in rats: In vivo study

scientific article

Fas-mediated apoptosis in adriamycin-induced cardiomyopathy in rats: In vivo study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/01.CIR.102.5.572
P698PubMed publication ID10920071

P2093author name stringNakamura T
Takahashi H
Ueda Y
Katsuda S
Koh E
Juan Y
P2860cites workBcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell deathQ24312211
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectcardiomyopathyQ847583
apoptotic processQ14599311
P304page(s)572-578
P577publication date2000-08-01
P1433published inCirculationQ578091
P1476titleFas-mediated apoptosis in adriamycin-induced cardiomyopathy in rats: In vivo study
P478volume102

Reverse relations

cites work (P2860)
Q37230844A standardized extract of Ginkgo biloba suppresses doxorubicin-induced oxidative stress and p53-mediated mitochondrial apoptosis in rat testes
Q41817128Activation of nuclear factor-kappaB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide
Q41376836Acute adriamycin-induced cardiotoxicity is exacerbated by angiotension II
Q80497061Adriamycin induces myocardium apoptosis through activation of nuclear factor kappaB in rat
Q33186335Amlodipine inhibits doxorubicin-induced apoptosis in neonatal rat cardiac myocytes
Q46374464Angiopoietin-1 inhibits doxorubicin-induced human umbilical vein endothelial cell death by modulating fas expression and via the PI3K/Akt pathway
Q36846891Anthracycline-induced chronic cardiotoxicity and heart failure
Q42045584Anti-Fas gene therapy prevents doxorubicin-induced acute cardiotoxicity through mechanisms independent of apoptosis
Q45876859Antiangiogenic systemic gene therapy combined with doxorubicin administration induced caspase 8 and 9-mediated apoptosis in endothelial cells and an anti-metastasis effect.
Q44417049Antioxidants attenuate myocyte apoptosis and improve cardiac function in CHF: association with changes in MAPK pathways
Q47109012Apoptosis and remodeling in adriamycin-induced cardiomyopathy rat model
Q35642302Apoptosis in Anthracycline Cardiomyopathy
Q63915349Apoptosis in the cardiovascular system: incidence, regulation, and therapeutic options
Q43865653Apoptosis in young rats with adriamycin-induced cardiomyopathy--comparison with pirarubicin, a new anthracycline derivative
Q35770967Apoptosis-detecting radioligands: current state of the art and future perspectives
Q41672498Attenuation of doxorubicin-induced cardiotoxicity by esculetin through modulation of Bmi-1 expression
Q40459939CD95/Apo-1/Fas: independent cell death induced by doxorubicin in normal cultured cardiomyocytes.
Q28388746Cardiac-targeted expression of soluble fas attenuates doxorubicin-induced cardiotoxicity in mice
Q33604134Cardiomyocyte death in doxorubicin-induced cardiotoxicity
Q35657122Cardiomyocyte death: mechanisms and translational implications
Q43151456Cardioprotective effect of metformin against doxorubicin cardiotoxicity in rats
Q36609796Caspase-dependent and -independent suppression of apoptosis by monoHER in Doxorubicin treated cells.
Q36768874Cell suicide and caspases
Q39664570Cytoprotective effects of acidosis via heat shock protein HSP27 against the anticancer drug doxorubicin
Q39486513Davallialactone protects against adriamycin-induced cardiotoxicity in vitro and in vivo
Q37330749Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell death
Q51742732Diazoxide Improves Mitochondrial Connexin 43 Expression in a Mouse Model of Doxorubicin-Induced Cardiotoxicity.
Q52570040Disruption of COX-2 modulates gene expression and the cardiac injury response to doxorubicin.
Q28579647Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium
Q30411254Doxorubicin impairs the insulin-like growth factor-1 system and causes insulin-like growth factor-1 resistance in cardiomyocytes
Q43847020Doxorubicin induces apoptosis and CD95 gene expression in human primary endothelial cells through a p53-dependent mechanism.
Q44822086Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. intermediacy of H(2)O(2)- and p53-dependent pathways
Q37704467Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes
Q39888881Doxorubicin-induced mitochondrial dysfunction is secondary to nuclear p53 activation in H9c2 cardiomyoblasts
Q28345320Dynamic process of apoptosis in adult rat cardiomyocytes analyzed using 48-hour videomicroscopy and electron microscopy: beating and rate are associated with the apoptotic process
Q46987056Dystrophin-deficiency increases the susceptibility to doxorubicin-induced cardiotoxicity
Q46800575Effects of doxorubicin-containing chemotherapy and a combination with L-carnitine on oxidative metabolism in patients with non-Hodgkin lymphoma
Q41771261Enhanced myocardial fluorodeoxyglucose uptake following Adriamycin-based therapy: Evidence of early chemotherapeutic cardiotoxicity?
Q28343555Ethanol-induced apoptosis in mouse liver: Fas- and cytochrome c-mediated caspase-3 activation pathway
Q42918384Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT.
Q40598968Glutathione S-transferase overexpression protects against anthracycline-induced H9C2 cell death
Q36674093HSP25 down-regulation enhanced p53 acetylation by dissociation of SIRT1 from p53 in doxorubicin-induced H9c2 cell apoptosis
Q35753015Hsp70 may protect cardiomyocytes from stress-induced injury by inhibiting Fas-mediated apoptosis
Q35078142Identification of novel biomarkers for doxorubicin-induced toxicity in human cardiomyocytes derived from pluripotent stem cells.
Q53626755Iloprost attenuates doxorubicin-induced cardiac injury in a murine model without compromising tumour suppression.
Q34760735Increased beta2-adrenoceptors in doxorubicin-induced cardiomyopathy in rat.
Q44164912Indium 111 antimyosin and Tc-99m glucaric acid for noninvasive identification of oncotic and apoptotic myocardial necrosis
Q21284499Induction of Ankrd1 in Dilated Cardiomyopathy Correlates with the Heart Failure Progression
Q39950138Induction of several cytochrome P450 genes by doxorubicin in H9c2 cells.
Q64094617Leveraging the Cardio-Protective and Anticancer Properties of Resveratrol in Cardio-Oncology
Q34295053Liguzinediol improved the heart function and inhibited myocardial cell apoptosis in rats with heart failure
Q34056422Long noncoding RNA MRUL promotes ABCB1 expression in multidrug-resistant gastric cancer cell sublines
Q37392811Matricellular protein CCN1 mediates doxorubicin-induced cardiomyopathy in mice.
Q36135119Mechanism of QSYQ on anti-apoptosis mediated by different subtypes of cyclooxygenase in AMI induced heart failure rats
Q38038803Mechanism of the protective action of taurine in toxin and drug induced organ pathophysiology and diabetic complications: a review
Q35697472Mechanisms of apoptosis in the heart
Q38388877Melatonin Prevents Mitochondrial Damage Induced by Doxorubicin in Mouse Fibroblasts Through Ampk-Ppar Gamma-Dependent Mechanisms
Q35902403MiR-21 Protected Cardiomyocytes against Doxorubicin-Induced Apoptosis by Targeting BTG2.
Q35274471MicroRNA-532-3p regulates mitochondrial fission through targeting apoptosis repressor with caspase recruitment domain in doxorubicin cardiotoxicity
Q35668883Mitochondria play a critical role in cardioprotection
Q40521043Mitochondrial mechanism of heat stress-induced injury in rat cardiomyocyte
Q38166071Molecular basis of cancer-therapy-induced cardiotoxicity: introducing microRNA biomarkers for early assessment of subclinical myocardial injury
Q34443183Molecular mechanisms of apoptosis in the cardiac myocyte
Q36496257Monitoring chemotherapy-induced cardiotoxicity: role of cardiac nuclear imaging
Q43050245N,N-Dimethyl phytosphingosine sensitizes HL-60/MX2, a multidrug-resistant variant of HL-60 cells, to doxorubicin-induced cytotoxicity through ROS-mediated release of cytochrome c and AIF.
Q35260701Noninvasive molecular imaging of apoptosis in a mouse model of anthracycline-induced cardiotoxicity
Q37090521Over-expression of a modified bifunctional apoptosis regulator protects against cardiac injury and doxorubicin-induced cardiotoxicity in transgenic mice
Q36568908Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection.
Q53755850Pentoxifylline abrogates cardiotoxicity induced by the administration of a single high dose or multiple low doses of doxorubicin in rats.
Q40591772Pifithrin-alpha protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice
Q47862697Plasma membrane alteration is an early signaling event in doxorubicin-induced apoptosis in the yeast Candida utilis
Q46960036Preventive cardioprotection of erythropoietin against doxorubicin-induced cardiomyopathy
Q35063194Regulation of cardiac myocyte cell death
Q61809301Rosmarinic acid alleviates cardiomyocyte apoptosis via cardiac fibroblast in doxorubicin-induced cardiotoxicity
Q41813615Targeted ultrasound imaging of apoptosis with annexin a5 microbubbles in acute Doxorubicin-induced cardiotoxicity.
Q35095412Targeting ischemic cardiac dysfunction through gene transfer
Q42937750Tempero-spatial dissociation between the expression of Fas and apoptosis after coronary occlusion
Q34494900Thymol and Carvacrol Prevent Doxorubicin-Induced Cardiotoxicity by Abrogation of Oxidative Stress, Inflammation, and Apoptosis in Rats
Q46769518Transcriptional analysis of doxorubicin-induced cardiotoxicity
Q47572376Trastuzumab therapy and the heart: palliation at what cost?
Q79769921Vasculitis induced by immunization with Bacillus Calmette-Guérin followed by atypical mycobacterium antigen: a new mouse model for Kawasaki disease
Q83034995miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1

Search more.